These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32396754)

  • 1. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women.
    Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E
    Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study.
    Hersant B; SidAhmed-Mezi M; Belkacemi Y; Darmon F; Bastuji-Garin S; Werkoff G; Bosc R; Niddam J; Hermeziu O; La Padula S; Meningaud JP
    Menopause; 2018 Oct; 25(10):1124-1130. PubMed ID: 29738415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Benefits of CO
    Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M
    Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study.
    Mercier J; Morin M; Lemieux MC; Reichetzer B; Khalifé S; Dumoulin C
    Menopause; 2016 Jul; 23(7):816-20. PubMed ID: 27219835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
    Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
    Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.
    Pérez-López FR; Phillips N; Vieira-Baptista P; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):746-752. PubMed ID: 34169794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
    Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
    Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
    Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
    J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P; Tagliaferri V; Amar ID; Cipolla C; Ingravalle F; Scambia G; Ricciardi W; Lanzone A
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study.
    Origoni M; Cimmino C; Carminati G; Iachini E; Stefani C; Girardelli S; Salvatore S; Candiani M
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4190-4195. PubMed ID: 27831658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
    Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
    Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: a pilot study.
    Condemi L; Di Giuseppe J; Delli Carpini G; Garoia F; Frega A; Ciavattini A
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8480-8486. PubMed ID: 30556890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
    Simon JA; Kagan R; Archer DF; Constantine GD; Bernick B; Graham S; Mirkin S
    Climacteric; 2019 Aug; 22(4):412-418. PubMed ID: 30862193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.